Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood Maria Kingbäck, Louise Karlsson, Anna-Lena Zackrisson, Björn Carlsson, Martin Josefsson, Finn Bengtsson, Johan Ahlner, Fredrik C. Kugelberg Forensic Science International Volume 214, Issue 1, Pages 124-134 (January 2012) DOI: 10.1016/j.forsciint.2011.07.034 Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Enantiomeric (S/R) concentration ratios for venlafaxine (VEN) and its metabolites O-desmethylvenlafaxine (ODV), N-desmethylvenlafaxine (NDV) and N,O-didesmethylvenlafaxine (DDV) in femoral blood after dividing the cases into CYP2D6 genotypes (0 active genes n=6, 1 active gene n=24 and 2 active genes n=23). Values are means±SD. Forensic Science International 2012 214, 124-134DOI: (10.1016/j.forsciint.2011.07.034) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions
Fig. 2 Metabolite/parent drug (M/P) concentration ratios and total (S+R) concentration for venlafaxine (VEN) and its metabolites O-desmethylvenlafaxine (ODV), N-desmethylvenlafaxine (NDV) and N,O-didesmethylvenlafaxine (DDV) in femoral blood after dividing the cases into CYP2D6 genotypes (0 active genes n=6, 1 active gene n=24 and 2 active genes n=23). Values are means±SD. Forensic Science International 2012 214, 124-134DOI: (10.1016/j.forsciint.2011.07.034) Copyright © 2011 Elsevier Ireland Ltd Terms and Conditions